PATENT CLAIM ANALYSIS

Application Number: 16122713
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2018-12
Patent Classification: ["435", "006100"]

Abstract:
Provided herein are biomarkers, and combinations of biomarkers, for predicting sensitivity to cancer treatments.

Claim (Index 3):
The method of  claim 1 , wherein the presence of the mutation to AKT correlates with decreased sensitivity of the cell to an an allosteric AKT inhibitor.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 97.0
- Lexical Diversity: 1.13333
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14832594', '15974533', '15017315', '14009320', '15438277']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6475724912135653
- 35 USC 102 Novelty (BERT): 0.5265911812727562
- Combined Prediction Score: 0.6354743602194844
- Mean Citation Score: 308.31905399999994
- Max Citation Score: 347.06223
- Similarity Product: 260.6672094629717

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test